Compugen reported $954K in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Compugen USD 954K 116K Sep/2025
RedHill Biopharma USD 89.8K 31.69M Jun/2024